|
Volumn 11, Issue 3, 1998, Pages 663-673
|
Thrombolytic therapy for venous thrombosis and pulmonary embolism
|
Author keywords
Bleeding risk; Efficacy; Pulmonary embolism; Streptokinase; Surrogate endpoint; Thrombolysis; Tissue plasminogen activator; Urokinase; Venous thrombosis
|
Indexed keywords
ALTEPLASE;
FIBRINOLYTIC AGENT;
HEPARIN;
STREPTOKINASE;
UROKINASE;
BLEEDING;
BLOOD CLOT LYSIS;
DEEP VEIN THROMBOSIS;
DRUG EFFICACY;
FIBRINOLYTIC THERAPY;
HEART RIGHT VENTRICLE FAILURE;
HUMAN;
HYPOXIA;
INTRAVENOUS DRUG ADMINISTRATION;
LEG THROMBOSIS;
LUNG EMBOLISM;
MORTALITY;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RESPIRATORY DISTRESS;
REVIEW;
VEIN BLOOD FLOW;
|
EID: 0032460667
PISSN: 09503536
EISSN: None
Source Type: Journal
DOI: 10.1016/S0950-3536(98)80088-7 Document Type: Article |
Times cited : (19)
|
References (65)
|